PEPTO-BISMOL LIQUID OTC
Generic Name and Formulations:
Bismuth subsalicylate 262mg/15mL; susp; sugar-free; original- or cherry-flavor.
Procter & Gamble Pharmaceuticals
Indications for PEPTO-BISMOL LIQUID:
Take caplets with water; do not chew. 2 tabs or caplets or 30mL every 30–60 minutes if needed; max 8 doses/day.
Varicella or influenza in children and teenagers.
Coagulation disorders. Diabetes. Reye's syndrome. Pregnancy. Nursing mothers: not recommended.
Potentiates oral anticoagulants, hypoglycemics. Antagonizes uricosurics. Salicylism with aspirin. Reduces tetracycline absorption.
Darkened tongue and/or stool.
Chew tabs—12, 30, 48; To-Go chew tabs—12, 24; InstaCool (peppermint flavor) chew tabs—30; Caplets—24, 40; Liq—4oz, 8oz, 12oz, pt; Max Str—4oz, 8oz, 12oz
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|